Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study
2005 ◽
Vol 54
(9)
◽
pp. 926-931
◽